Biochemical and Biophysical Research Communications
Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGFβ-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells
Research highlights
► Stimulation with TGF-β3 upregulates the chondrogenic response of Mesenchymal Stem Cells via the ERK1/2 MAPK pathway. ► Activation of ERK1/2 is essential for the cytokine-induced chondrogenesis and osteogenesis of Mesenchymal Stem Cells. ► Inhibition of ERK phosphorylation does not augment the osteogenic response of MSCs when stimulated by cytokine exposure.
Introduction
Mesenchymal stem cells (MSCs) are multipotent cells that can be harvested from multiple types of tissues in the human body [1]. MSCs were first described as marrow stromal cells in the 1970s [2]. The emergence of MSCs as an important tool in regenerative medicine is due to their capability to repopulate and differentiate into several tissue lineages, including both cartilage and bone. MSCs are considered the natural source for tissue self-repair [3] and prove to be popular in stem cell based research because of their abundant availability and their circumvention of ethical issues that are inherent with other lineages such as embryonic stem cells. In fact, numerous clinical trials have already shown the potential and benefit of using MSCs for various disorders [4], [5]. It has been shown that MSCs can effectively be differentiated into several tissue lineages when placed under specific conditions [6]. MSCs are most commonly used in bone as well as cartilage regeneration [7], [8] and recent experiments show promising results that, 1 day, cellular therapies for bone and cartilage related disease(s) can become common practice in the medical field [9], [10], [11].
It is known that during the differentiation process of MSCs, one or several intracellular chemical cascades are modified (activated or inhibited) influencing the ultimate commitment of the cell. However, it remains unclear how each individual pathway affects the differentiation program of the cells and how manipulation of these pathways could lead to more efficient differentiation protocols. Understanding the underlying mechanisms that guide and control these intracellular cascades and their ultimate effect on cellular commitment could help harness the MSCs differentiation potential towards more effective tissue engineering and cellular-based therapy applications. Some of the most commonly studied pathways in mesenchymal stem cell chondro- and osteogenesis are the mitogen activated protein kinase (MAPK) pathways. The MAPK refers to a family of signal transduction pathways that have been conserved within eukaryotic cells throughout evolution. The three major MAPK pathways consist of the extracellular signal-regulated kinases (ERK), p38 MAP kinase, and the c-Jun N-terminal kinase (JNK) [12]. MAPKs respond to extracellular stimuli such as hormones, growth factors, and oxidative and mechanical stress by serial phosphorylation of proteins within the cascade. As a result, MAPKs have both activating and inhibiting roles in important physiological events such as proliferation, differentiation, and apoptosis [13]. A recent study from the Rensselaer Polytechnic Institute (RPI) [14] noted that inhibition of the ERK1/2 pathway led to an inhibition of chondrogenesis and to an amplification of the osteogenic program in human MSCs when stimulated by a three-dimensional type I collagen matrix culture. This study also suggested that the three-dimensional microenvironment configuration led to the upregulation of chondrogenic and osteogenic gene expression rather than the biochemical stimulation of the cells by a defined media (as no differentiating moieties were employed) or by the collagen I substrate (the predominant type of collagen in bone). ERK1/2 was the first signaling transduction pathway of the MAPKs that was heavily characterized and is considered one of the principal pathways that controls cell proliferation, differentiation, and overall survival of cells [15]. In terms of differentiation, ERK1/2 has been shown to be important both for both osteogenesis and chondrogenesis [16], [17]. However, whether ERK1/2 is stimulatory or inhibitory to these processes remains unclear due to the amount of conflicting results in the field.
For example, in terms of osteogenesis, it has been suggested that ERK1/2 suppresses osteogenic differentiation in osteoblastic progenitor cell populations [18] and is at least partially non-critical for the hydrostatic pressure-induced osteogenesis of bone marrow MSCs [19]. However, it has also been suggested that inhibition of ERK1/2 abolishes the osteogenic response of adipose derived MSCs [20] which would imply that ERK1/2 is necessary for osteogenesis. Moreover, other studies with bone marrow-MSCs show that the inhibition of ERK1/2 amplifies osteogenesis [14]. Further, there is much ambiguity in the control that ERK1/2 has during chondrogenic differentiation of stem cells. For instance, Oh et al. (2000) showed that ERK1/2 phosphorylation decreased during chondrogenic differentiation of the chick mesenchyme [21]. In a similar cell system, Yoon et al. [22] showed that inhibition of chondrogenesis increased phosphorylation of ERK1/2; thus showing an anti-chondrogenic role of ERK1/2. However, there have been numerous reports of ERK1/2 being vital for chondrogenic differentiation of stem cells. Some studies revealed that the activation of ERK1/2 is necessary for the induction of the chondrogenic gene SOX-9 [23], [24], [25]. Hence, more research is required to fully understand the role of ERK1/2 in the processes of osteogenic and chondrogenic differentiation.
While it is clear that micro-environmental cues are by themselves capable of stimulating cells towards a differentiation pathway, it is unclear to what degree this induction activates the same chemical cascades and reaction kinetics observed with the biochemical induction via cytokine exposure. Successful differentiation of MSCs towards a chondrogenic and osteogenic lineage has been widely achieved in the past by means of soluble factor induction with cytokines from the TGF-β superfamily [26]. Similarly, researchers have demonstrated the need for the presence of extracellular inorganic phosphate–calcium complexes in order for successful osteogenic differentiation of progenitor cells to occur [27]. This same study also found that the exposure of the cells to the inorganic phosphate–calcium precipitates (CaPp) induced the phosphorylation of the ERK1/2 pathway in as little as 30 min of culture. The subsequent inhibition of ERK1/2 phosphorylation by means of the drug U0126 led to an elimination of the observed osteogenic marker upregulation [27].
Given the contradictory nature of the reports published on the role of ERK1/2 in the osteogenic and chondrogenic differentiation of cells as induced by either environmental/matrix interactions or by cytokine/soluble factor induction, it is necessary to further explore the role of this MAPK pathway in these processes. This project focuses on the activation of the ERK1/2 in cells stimulated by TGF-β3 and investigates the role of ERK1/2 in MSC chondrogenic and osteogenic differentiation via cytokine exposure.
Section snippets
Materials and methods
All cell culture reagents were purchased from Invitrogen (Carlsbad, CA) unless otherwise specified. Inhibitor PD98059, L-Ascorbic Acid, β-glycerophosphate, dexamethasone, and human recombinant TGF-β3 were all purchased from Sigma–Aldrich (St. Louis, MO).
Phosphorylated ERK (pERK) 1/2 quantification
The results of the ELISA specific for phosphorylated ERK1/2 are seen in the figure below (Fig. 1). The x-axis displays the three experimental groups tested and the y-axis displays the relative quantities of phosphorylated ERK1/2 (standardized to the level of the control group). It is observed that the TGF-β3 + dexamethasone treatment (treated group) significantly activated the ERK1/2 pathway. The administration of PD98059 to the inhibited group, successfully blocked the ERK1/2 signaling pathway
Discussion
Given the possible combinations of cell sources, culture conditions and other undefined variables introduced into most biological systems, it is often hard to compare, discern and ultimately, optimize biological processes in terms of the observed outcomes. Predicting the interaction of these processes is further complicated by reports in the literature present solid validated data which seem, at first sight, to present opposing types of results. Here we sought to shed light on the role of the
Acknowledgments
The authors would like to thank Dr. Tammy Laberge MacDonald for her insightful critiques of the project and her help in editing the final version of this article.
References (30)
- et al.
Optimizing mesenchymal stem cell-based therapeutics
Curr. Opin. Biotechnol.
(2009) - et al.
Notch signaling during chondrogenesis of human bone marrow stem cells
Bone
(2010) - et al.
The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats
Bone
(2010) - et al.
Mesenchymal stem cells for bone repair and metabolic bone diseases
Mayo Clin. Proc.
(2009) - et al.
Mesenchymal stem cells as a potential pool for cartilage tissue engineering
Ann. Anat.
(2008) - et al.
MAP kinases in chondrocyte differentiation
Dev. Biol.
(2003) - et al.
MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis
Exp. Cell Res.
(2006) - et al.
Mechanisms of bone repair and regeneration
Trends Mol. Med.
(2009) - et al.
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation–divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation
Osteoarthritis Cartilage
(2010) - et al.
Hydrostatic pressure promotes Wnt10b and Wnt4 expression dependent and independent on ERK signaling in early-osteoinduced MSCs
Biochem. Biophys. Res. Commun.
(2009)
Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes
J. Biol. Chem.
Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-alpha, Erk-1, and p38 MAPK signaling pathways
J. Biol. Chem.
P38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells
Exp. Cell Res.
Involvement of Gas7 along the ERK1/2 MAP kinase and SOX9 pathway in chondrogenesis of human marrow-derived mesenchymal stem cells
Osteoarthritis Cartilage
CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway
J. Biol. Chem.
Cited by (36)
Customized triphasic cartilage composite scaffold simulating hypoxic microenvironment for osteochondral regeneration
2024, Composites Part B: EngineeringGeneration of hyaline-like cartilage tissue from human mesenchymal stromal cells within the self-generated extracellular matrix
2022, Acta BiomaterialiaCitation Excerpt :After IGF1 binds and phosphorylates the type 1 tyrosine kinase receptor (IGF1R), the biological action is transmitted into cells, and the mitogen-activated protein kinase (MAPK) pathways are activated classically [35]. Furthermore, as an essential member of the MAPK family, extracellular signal-regulated kinases 1/2 (ERK1/2) has been demonstrated to be implicated in MSC chondrogenesis and osteogenesis [36]. Thus, IGF1 and ERK1/2 may participate in MSC chondrogenic differentiation and hypertrophy when responding to hypoxic culture, which requires further investigation.
The role of aryl hydrocarbon receptor in bone remodeling
2018, Progress in Biophysics and Molecular BiologyCitation Excerpt :ERK1/2 could increase eNOS and decrease RANKL (Rubin et al., 2003), and result in enhancing bone formation and reducing bone loss. Activation ERK1/2 is necessary for TGF-β to induce the differentiation of mesenchymal stem cells to osteocyte (Arita et al., 2011). MAPKs plays an important role in the process of osteoblast's development.
Heart defects and other features of the 22q11 distal deletion syndrome
2013, European Journal of Medical GeneticsCitation Excerpt :One patient had more severe growth retardation and was diagnosed clinically with Silver Russel syndrome [27]. MAPK1/3 signaling has been shown to have an important role in regulating hypertrophic chondrocyte apoptosis in the growth plates in mice [28], and it is needed for TGFβ-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells [29]. Furthermore, the insulin receptor and the insulin-like growth factor-1 receptor activate the MAPK pathway [30].